Combined cimetidine-pirensepine formulation for treating peptic ulcers and erosions
AssigneeBioMed Researchy Consultants, Ltd.
InventorHelmut O. Kohler
Life of this patent
Estimating the term…
Abstract
An orally administered pharmaceutical composition for treating peptic ulcers and other gastrointestinal conditions associated with hyperacidity, which includes both the H.sub.2 -receptor antagonist cimetidine and the antimuscarinic agent pirenzepine.
Claims14
An orally administered pharmaceutical composition in dosage form for treating gastrointestinal dysfunction, consisting essentially of an orally effective amount of cimetidine and an orally effective amount of pirenzepine in proportions effective to treat gastrointestinal dysfunction.
A method for treating a patient for gastrointestinal dysfunction which comprises orally administering to the patient a pharmaceutical composition in dosage form, consisting essentially of an orally effective amount of cimetidine and an orally effective amount of pirenzepine in proportions effective to treat gastrointestinal dysfunction.
Dependencies are inferred from the claim text.